Papaya extract pills show promise in treating chemotherapy-related low platelets

Medical researchers have identified a potential breakthrough in managing one of chemotherapy's most debilitating side effects: dangerously low platelet counts. A new therapeutic approach using papaya extract in pill form is demonstrating encouraging results in helping cancer patients recover their blood's clotting ability after intensive treatment.

Chemotherapy-induced thrombocytopenia, the medical term for low platelet levels following cancer treatment, affects a significant portion of patients undergoing aggressive drug regimens. This condition forces doctors to administer frequent blood transfusions and restricts patients' daily activities due to bleeding risks. The traditional management approach relies heavily on transfusions and supportive care, creating both logistical challenges and patient burden.

The papaya extract treatment works by stimulating the bone marrow's natural platelet production mechanisms. Researchers found that the concentrated botanical compound triggers the body's own regenerative response, potentially reducing the need for external blood products. The pill formulation makes the treatment convenient for outpatient administration, allowing cancer patients to manage the condition at home rather than through repeated hospital visits.

For Mumbai's cancer care infrastructure and the broader Indian healthcare system, this development holds significant implications. India has one of the world's highest cancer patient populations, and affordable, natural treatment options could dramatically improve quality of life for thousands of patients undergoing chemotherapy. The papaya extract approach also aligns with India's traditional medicine knowledge, potentially making it more accessible across different economic classes.

Clinical trials are progressing to establish optimal dosage and long-term efficacy. Medical oncologists at major Indian institutions are participating in multi-centre studies to validate these preliminary findings. If approved for wider use, the papaya extract pills could become a standard supportive care measure alongside chemotherapy protocols, particularly benefiting patients in resource-limited settings where blood bank access remains challenging.

Experts suggest this discovery represents a shift toward integrating traditional botanical knowledge with modern pharmaceutical science. Further research will determine whether the extract can be combined with other supportive treatments to maximise patient outcomes and reduce overall treatment toxicity.

Source: Times of India